Automated Molecular PCR Platform
NHS Blood and Transplant · Awarded
- Buyer
- NHS Blood and Transplant
- Status
- Awarded
- Country
- United Kingdom
- Region
- EU - Western Europe
- Sector
- Manufacturing
- Reference
- UK-CFA-ocds-b5fd17-91ed65f2-31ef-427c-9cef-e4e24473a4e8
- Published
- 2026-02-18
- Deadline
- 2025-11-03
Tender summary
In May 2023, universal, post-donation screening for HHV-8 antibodies was added to the portfolio of tests required for deceased organ donor characterisation in the UK. Routine pre-donation testing for other required infection markers continue to be performed on an urgent 24/7 basis by a network of UK wide NHS diagnostic laboratories. MSL Virology require a fully automated platform to perform testing for HHV8 DNA in plasma and whole blood samples. MSL Virology also requires a fully automated platform to perform testing for CMV DNA, HEV RNA and HBV DNA in EDTA plasma samples.
This is a public summary of a procurement notice. Dates and status reflect the notice held by BidScout; check the full notice before bidding.
Full tender details have a three-minute guest preview for open opportunities. AI insights require registration.
Register for full access